glp 1 approved for pcos GLP-1 medications are not by the Food and Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label GLP-1, SGLT2 combination therapy provides

Once opened, refrigerate if you want to extend shelf life, though unopened bacteriostatic water is stable at room temperature

You can take both together at the same time or within a short interval (around 1530 minutes apart)

it was developed in 1995 and approved for marketing in 2005

The results from the SUSTAIN 6 trial indicated that patients treated with semaglutide experienced a significantly higher incidence of DR compared to those receiving placebo (86)

This distinction matters for patients who ask "does Medicaid cover Ozempic for weight loss?" The answer is usually no, because Ozempic does not carry an FDA indication for weight management

PDE5 Inhibitors The comparison comes down to where in the sequence each treatment acts